Abstract:Alzheimer's disease (AD) is a severe irreversible neurodegenerative disease that has great sufferings on patients and eventually leads to death. Early detection of AD and its prodromal stage, mild cognitive impairment (MCI) which can be either stable (sMCI) or progressive (pMCI), is highly desirable for effective treatment planning and tailoring therapy. Recent studies recommended using multimodal data fusion of genetic (single nucleotide polymorphisms, SNPs) and neuroimaging data (magnetic resonance imaging (MRI) and positron emission tomography (PET)) to discriminate AD/MCI from normal control (NC) subjects. However, missing multimodal data in the cohort under study is inevitable. In addition, data heterogeneity between phenotypes and genotypes biomarkers makes learning capability of the models more challenging. Also, the current studies mainly focus on identifying brain disease classification and ignoring the regression task. Furthermore, they utilize multistage for predicting the brain disease progression. To address these issues, we propose a novel multimodal neuroimaging and genetic data fusion for joint classification and clinical score regression tasks using the maximum number of available samples in one unified framework using convolutional neural network (CNN). Specifically, we initially perform a technique based on linear interpolation to fill the missing features for each incomplete sample. Then, we learn the neuroimaging features from MRI, PET, and SNPs using CNN to alleviate the heterogeneity among genotype and phenotype data. Meanwhile, the high learned features from each modality are combined for jointly identifying brain diseases and predicting clinical scores. To validate the performance of the proposed method, we test our method on 805 subjects from Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset. Also, we verify the similarity between the synthetic and real data using statistical analysis. Moreover, the experimental results demonstrate that the proposed method can yield better performance in both classification and regression tasks. Specifically, our proposed method achieves accuracy of 98.22%, 93.11%, and 97.35% for NC vs. AD, NC vs. sMCI, and NC vs. pMCI, respectively. On the other hand, our method attains the lowest root mean square error and the highest correlation coefficient for different clinical scores regression tasks compared with the state-of-the-art methods.

An efficient ranking-based ensembled multiclassifier for neurodegenerative diseases classification using deep learning

Enhancing healthcare recommendation: transfer learning in deep convolutional neural networks for Alzheimer disease detection

Early Diagnosis of Alzheimer's Disease Using Deep Learning

Deep Convolutional Neural Network based Classification of Alzheimer's Disease using MRI data

Joint Multiclass Classification of the subjects of Alzheimer's and Parkinson's Diseases through Neuroimaging Modalities and Convolutional Neural Networks.

Deep ensemble learning for Alzheimers disease classification

Classification of Alzheimer's Disease Using Ensemble of Deep Neural Networks Trained Through Transfer Learning

A deeply supervised adaptable neural network for diagnosis and classification of Alzheimer's severity using multitask feature extraction

Development and validation of a deep learning framework for Alzheimer’s disease classification

Classification of Alzheimer’s Disease Using Ensemble of Deep Neural Networks Trained Through Transfer Learning

3-1-3 Weight averaging technique-based performance evaluation of deep neural networks for Alzheimer's disease detection using structural MRI

Alzheimer's disease diagnosis framework from incomplete multimodal data using convolutional neural networks

Ensemble deep learning approach for early diagnosis of Alzheimer's disease

Ensemble of Convolutional Neural Networks and Multilayer Perceptron for the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease

Deep Convolutional Neural Networks With Ensemble Learning and Generative Adversarial Networks for Alzheimer’s Disease Image Data Classification

Multimodal Alzheimer's disease classification through ensemble deep random vector functional link neural network

Deep learning-based classification of multi-categorical Alzheimer's disease data.

Deep learning based pipelines for Alzheimer's disease diagnosis: A comparative study and a novel deep-ensemble method

An Ensemble of the Convolutional Neural Network Model with Fuzzy Fusion Rank Algorithm for the Identification of Parkinson’s Disease Using Magnetic Resonance Imaging Images

Deep Learning in Alzheimer's Disease: Diagnostic Classification and Prognostic Prediction Using Neuroimaging Data

Classification of Alzheimer disease using DenseNet-201 based on deep transfer learning technique